Background: Normative values for fractional exhaled nitric oxide (FeNO) and the associated co-factors are important in understanding the role of FeNO as a biomarker in airway disease. The objective of this study is to establish reference FeNO values for youth and adult asymptomatic, lifetime nonsmokers in the United States, and to describe the factors affecting these levels. Methods: Cross-sectional analyses of the National Health and Nutrition Examination Survey from 2007 to 2010. The analytic sample consisted of 4718 youth and adults, ages 6e79 years, who were lifelong nonsmokers, and free of asthma, and other respiratory conditions and symptoms. Log e FeNO values were used as dependent variables to test associations of demographic and health related-covariates. Multivariable regression models were used to assess the independent effect and covariate-adjusted contribution of the factors. Results: The geometric mean FeNO level was 8.3, 12 
Background
Fraction of Exhaled Nitric Oxide (FeNO) is a noninvasive marker of airway inflammation [1] . With validated handheld portable electrochemical analyzers [2e7], FeNO can be assessed more readily in research and in clinical practice [8, 9] . FeNO measurements are used by clinicians as a tool to identify steroid responsiveness and to monitor adherence to steroid therapy in some asthmatic patients [10, 11] .
FeNO has been demonstrated to be influenced by several demographic, biochemical and physiologic factors. FeNO levels have been shown to be consistently higher in persons with respiratory conditions, including asthma as compared to healthy people [12, 13] , and atopy [14e16] . Smoking is associated with lower FeNO levels [17, 18] .There have been inconsistent findings on the significance of other factors, including age [19e22] , gender [19,21e25] , race-ethnicity [26e29] height [19, 22, 26, 30] , and weight [21, 26, 28, 29] . The contribution of food and drink [31] including nitraterich foods prior to testing [32, 33] , the effect of environmental elements, such as second hand smoke [34, 35] , and diurnal variability [35e37] and FeNO have also been explored. These studies have differed in the constellation of factors examined, sample sizes, selection criteria, ages of study participants and study protocol.
Despite an accumulating literature on both the scientific and clinical role of FeNO in understanding airway inflammation, reference data on the population distribution of FeNO for children and adults in the U.S. are limited [38] . The National Health and Nutrition Examination Survey (NHANES), a large-scale national study of the noninstitutionalized population offers the unique opportunity to provide both FeNO reference estimates and to examine some of the important biological and external factors that have been associated with FeNO. See and Christiani [39] recently presented FeNO values and thresholds from these data showing the large variability in the population. The primary objective of this report is to provide FeNO values for U.S. children, adolescents and adults, free of respiratory symptoms or disease, and lifetime nonsmokers. A second objective is to assess the effect of age, gender, race-ethnicity and other factors that influence FeNO levels in this reference population.
Methods
The National Health and Nutrition Examination Survey, conducted by the Center for Disease Control and Prevention's National Center for Health Statistics, is a crosssectional survey, designed to assess the health and nutritional status of the civilian, non-institutionalized U.S. population. Since its inception in the early 1970s, the National Health and Nutrition Examination Surveys (NHANES) have periodically monitored the respiratory health status of the U.S. population using spirometry and other health measures. In 2007, NHANES expanded its respiratory health component to include FeNO measurements. Nationally representative samples are annually selected using a complex, multistage sampling design that employs probability, stratified and cluster sampling to produce estimates for the U.S. population. Beginning in 1999, NHANES became a continuous survey and public use data files are released in two year cycles. This paper is based on the combined 2005-2006 and 2007-2008 survey cycles, the first four years that fractional exhaled oxide (FeNO) was measured in NHANES. During this four year period, blacks, Hispanics, persons 60 years and older and low income persons were oversampled to produce more reliable estimates for these specific demographic subgroups.
The NHANES consists of an in-person home interview followed by a standardized physical examination in a mobile examination center (MEC). The interview includes questions on socio-demographic characteristics and other medical conditions. Signed informed consent was obtained by all examinees, and youths 7e11 years provided assent. Parents or guardians provided consent for youths younger than 16 years. The survey protocol was approved by the National Center for Health Statistics Ethical Review Board, Hyattsville, Maryland.
Of the 16,385 persons 6e79 years interviewed in NHANES 2007e2010, 15,938 individuals were examined. Among these, 378 persons were ineligible for the respiratory health examination because of reported pain or difficulty taking a deep breath or use of supplemental oxygen during the day. An additional 1251 persons were missing data due to insufficient time available to complete the FeNO exam, refusals, communication problems, equipment failure, or other such reasons. Data were also missing for 1034 persons who were either unable to provide a single FeNO measurement after up to 10 attempts (n Z 763), or to achieve at least two reproducible measurements (n Z 271). After, excluding one individual with measurements above the analyzer's upper limit of detection (300 ppb) as an outlier, 13,274 persons had reproducible FeNO measurements.
For this study, we selected a reference sample of persons free of any respiratory conditions and symptoms and lifetime nonsmokers, based primarily on responses to questions asked during the household interview or prior to the FeNO testing (Online supplement Table e-1) to determine our final analytic sample of 4718 persons. The sample for the normative FeNO study was approximately 36% of the NHANES participants with reproducible FeNO measurements. Children, adolescents and adults in the reference population, as compared to those not selected, differed slightly according to demographic and physical characteristics (Online supplement Table e-2). In all three study age groups (6e11, 12e19 and 20e79 years), participants in the reference sample were more likely to be female than those not selected. Adults were also slightly shorter, overall, than those adults who were not included.
Fractional exhaled nitric oxide measurements
FeNO concentration was measured in exhaled air prior to the spirometry exam. Measurements were determined at an expiratory flow rate of 50 ml/s using the NIOX MINO Ò , a portable, hand-held nitric oxide analyzer (Aerocrine AB, Solna, Sweden). This device relies on an electrochemical sensor to detect exhaled NO values from 5 to 300 ppb [2] . Values below 5 ppb are considered below the lower limit of detection (LOD) of the instrument and values above 300 ppb are above its upper detection limit. The standard exhalation time, as specified by the manufacturer, was 10 s for persons at or above 130 cm in height, and 6 s for youths below 130 cm. The testing protocol required two reproducible FeNO measurements in accordance with testing procedures recommended by the manufacturer and similar to the American Thoracic Society/European Respiratory Society criteria [38] . The mean of two reproducible FeNO measurements was used as the main outcome variable. Survey participants were coached by trained technicians and given a total of ten attempts to achieve two reproducible measurements. If the first two FeNO measurements were both below 30 ppb and within 2 ppb of each other, or if both were over 30 ppb and within 10% of each other, then an exam was considered reproducible and complete. Otherwise, up to two additional measurements were obtained for reproducibility. Two measurements below the limit of detection of the device (i.e., less than 5 ppb) were also considered reproducible and in these cases, a value of 3.5 ppb (LOD/O2) was used as the mean. Details of the protocol are available elsewhere [40] .
Other covariates
Self-reported information on race and ethnicity was categorized as non-Hispanic white, non-Hispanic black, and Hispanic. Persons who self-identified as any other raceethnicity were included in the total estimates only but are not presented as a separate category. For the FeNO estimates and percentiles for adult study population, age was categorized as 20e39, 40e59, 60e79 years. Income was calculated as the family income to poverty level ratio (FIPR) by dividing family income by a poverty threshold specific for family size and year of exam, and then categorized using a cut point of FIPR <1.3 for the lowest income group. Weight (kg) and height (cm), measured during the examination were also used to calculate body mass index (weight kg./height m 2 ). Although blood eosinophil count !500 cells/mL was initially used to exclude persons from the reference sample, counts of less than 500 cells/mL were further assessed as a covariate categorized as !200 cells/ mL and <200 cells/mL. Other covariates were time of testing (morning, afternoon, or evening session), reported family history of asthma, and exposure to second hand smoke inside the home. Responses to pre-examination questions (ages 12e79 years only) on factors reported to effect FeNO prior to the measurements were also assessed, including strenuous exercise in the last hour, food or drink in the last hour, and consumption of nitrate-rich meats or vegetables in the last 3 h.
Data analysis and statistical methods
Statistical analyses were performed using SAS, version 9.2 (SAS Institute, Cary, NC) and SAS-callable SUDAAN version 10.0 (Research Triangle Institute, Research Triangle Park, NC) was used to account for the complex survey design. All analyses were conducted using the NHANES examination weights to account for differential probabilities of selection, non-coverage and nonresponse, and to obtain estimates representative of the civilian, non-institutionalized U.S. population. Standard errors were estimated by Taylor Series Linearization using SUDAAN to account for the sample design. The LOESS procedure (Proc SGPLOT) in SAS was used to create the smoothed graphs for-age trends. This procedure uses locally weighted polynomial regression to fit a smoothed line. Trends in age were tested using Satterthwaite-adjusted F statistics from linear regressions. FeNO values are skewed; therefore, they were log e -transformed to normalize the distribution of FeNO measurements. Log e -transformed FeNO values were used to calculate geometric means and standard errors by age group, gender and race-ethnicity. Selected percentiles for FeNO were also calculated.
The log e FeNO values were also used as dependent variables to test associations of demographic and health related-covariates previously shown to be associated with FeNO. Associations were first tested using the Student ttest and simple linear regression. Multivariable regression models were used to assess the independent effect and covariate-adjusted contribution of the factors. Main effects were first tested and then two-way interactions were tested one at a time adding the interaction term to the original model. Interaction terms were not included in the final models because they did not significantly add to the fit of the models. Covariates that were independently associated with FeNO at a p 0.05 were considered for the final linear regression models. Separate regression analyses were performed for age groups 6e11 years, 12e19 years, and 20 years and older. The final models included persons in the three major race-ethnic subgroups.
Results
We found a significant linear trend (p < 0.001) of increasing FeNO level with increasing age overall for both men and women of all ages (Fig. 1 ). The age relationship was also present in the three race-ethnic subgroups (Fig. 2) . Table 1 presents the geometric mean, standard error, median, and 2.5th, 10th, 25th, 75th, 90th, and 97.5th percentile FeNO values by gender and race-ethnicity for three major age groups. The percent of persons with FeNO values below the instrument's limit of detection (5 ppb) is also shown. For children 6e11 years, the overall geometric mean FeNO value was 8.3 ppb (SE Z 0.2), and was 8.3 ppb (SE Z 0.3) and 8.4 ppb (SE Z 0.2), for boys and girls, respectively One-fifth of children 6e11 years had FeNO levels below the detection limit (5 ppb). Among youths 12e19 years, geometric mean FeNO value was 12.1 ppb, (SE Z 0.4); 13.5 ppb (SE Z 0.6) for boys, and 10.9 ppb (SE Z 0.4) for girls. Among adults 20e79, the geometric mean FeNO was 14.1 ppb (SE Z 0.2), and approximately 4 ppb higher in males than in females. The 90 th percentile was approximately twice that of the median. By finer age categories (Online supplement, Table e-3), geometric mean FeNO levels were lowest among 20e39 year olds (12.9 ppb) and highest among 60e79 year olds (17.3 ppb). Table 2 provides estimated geometric mean FeNO levels by baseline characteristics, and other possible confounders, in each of three age groups. By gender, both female adolescents and female adults had lower geometric mean FeNO levels than their male counterparts; although this difference was not seen in younger children. Differences in geometric mean values for FeNO varied with non-Hispanic blacks having higher values as compared to non-Hispanic whites, for the children and adolescents, but not for the adults. Geometric mean FeNO values increased with height (p < 0.001) within all three age groups (see also, Fig. 3 ). Geometric mean FeNO varied by time of day of FeNO testing across the age groups, with higher values found among those persons tested during the morning sessions (8:30 AMe12:00 PM) as compared with those tested in the afternoon and evening sessions. Adults who reported having food or a beverage an hour before the exam had slightly, although significantly, lower geometric mean FeNO values (13.9 ppb) than those who did not eat or drink (14.5 ppb), as did those who reported eating nitraterich vegetables up to 3 h before the exam (16.4 vs 14.0 ppb). Among children and adults, geometric mean FeNO levels were higher among persons with blood eosinophil counts greater than or equal to 200 but less than 500 cells/mL as compared to those with less than 200 cells/mL. There was no evidence of any significant difference in FeNO levels with BMI, second-hand smoke exposure, or family history of asthma in any age group.
The coefficients from multiple linear regression models of the log ln of FeNO, stratified by age group, are shown in Table 3 . Only the covariates that remained significant in either model are shown. Due to the colinearity of age and height in children and adolescents, age was not included in the models for these age groups. Among adults, FeNO levels increased with increasing age. Height, blood eosinophil count and time of exam session were independent predictors of FeNO values in all age group-specific models. The size and the direction of the coefficients were consistent across all models, but the statistical significance varied by age group. Race-ethnicity (non-Hispanic black and Hispanic) were associated with higher FeNO levels among children and adolescents but not adults, whereas gender (male) was associated with higher FeNO among adolescents and adults but not among children.
Discussion
In the present study we have provided FeNO geometric means and selected percentile estimates and have examined anthropologic, physiologic and other external and examination-related factors related to FeNO levels. Unlike the recent report of normal values and thresholds also based on the NHANES [39] we have limited our analyses of the population sample to lifelong nonsmoking healthy adults and children. Nonetheless, our results in an asymptomatic sample showed a similar wide range of variability of FeNO levels across demographic groups. Results of our multivariable regression modeling which included the significant demographic and physiologic predictors also explained little of the variability in our healthy, general population.
Differences in FeNO analyzers and measurement protocols, sample sizes, age groups and race-ethnic constituencies, and exclusionary criteria of reference populations in other studies make it difficult to compare findings. For the youngest children, 6e11 years, our geometric mean of 8.3 ppb was lower than that found in a 2009 study of California school children [27] (10.9 ppb), and closer to the mean reference value (8.7 ppb) for healthy children in Italy [30] , ages range 6e15 years. Few normative studies of FeNO levels have focused on the adolescent age group aged 12e19 years where we found a higher geometric mean FeNO level among young men (12.1 ppb) compared with young women, (10.9 ppb). A study of 11e18-year-old Hong Kong school children [28] also found gender differences among healthy controls although mean FeNO levels were higher. The geometric mean of our adult population (14.1 ppb) was similar to the geometric mean of 13.9 ppb found by Karrasch et al. [17] , and slightly lower than other normative adult studies. In a New Zealand study [22] of 25e75-year-olds, researchers found a geometric mean level of 17.9 ppb and a large study of 1131 adults in a general population in Sweden [19] reported a mean of 16.6 ppb among healthy adults.
A major finding of our study was that among youths (6e19 years) FeNO levels were higher in non-Hispanic blacks and Hispanics compared to non-Hispanic whites, a relationship not seen in adults. There is limited data on race-ethnic differences for FeNO in any age group. Kovesi et al. [26] found higher FeNO levels in African-Canadian children than among white children. Linn et al. [27] , found that FeNO levels were higher among young Hispanic and African-Americans children compared with nonHispanic white children, and, Asian children had the highest FeNO levels of any race or ethnic subgroup in their study. FeNO values in Chinese children [28, 29] were reported to be higher than among healthy non-Asians of other studies. While we did not observe race-ethnic differences among adults, studies of Korean adults [21] and of healthy, nonsmoking African Americans adults [23] both noted higher FeNO levels for their subjects compared with previously published studies of white adults, but neither of these study included subjects of other race or ethnicities. Our findings of FeNO differences by race-ethnicity only among youths are provocative. In a sensitivity analysis of youths that we conducted prior to any exclusions based on asthma or smoking status, young non-Hispanic blacks consistently showed higher mean FeNO levels as compared with young non-Hispanic whites. Thus, it is unlikely that the ethnic difference is due to chance. Although misclassification of our participants in our reference population is possible we would not expect a systematic bias in the reporting of symptoms by race-ethnicity. Our criteria for defining our reference population were stringent and methodical; our exclusion criteria were based on statistical testing of respiratory disease and related symptoms and conditions reported in the literature to be related to FeNO. However, other factors that we did not investigate may differentially affect children by race-ethnicity. Furthermore, race-ethnicity may serve as a proxy for other unmeasured factors, biological or environmental also related to FeNO [8, 41] . Nonetheless, the differences we observed in FeNO levels by race-ethnicity are novel and suggest the need for further investigation. We showed, overall, in our sample of persons 6e79 years of age, that FeNO levels increased linearly with age. In separate sensitivity analyses that we performed, age was highly correlated with height, especially among young children. In our models, age, height and gender all remained independent predictors of FeNO in adults. Other studies with adults with a broad age range [17, 19] have reported higher FeNO among persons in older age groups, as have studies of children and adolescents [20, 29, 34] . In contrast, Kovesi et al. [26] , in a sample of Canadian school children 9e12 years of age, and Baraldi et al. [30] , in a small sample of Italian school children 6e15 years of age, found that age was not an independent predictor of FeNO. Gender was an independent predictor in adolescents and adults, but not for the children. Gender has also been widely reported as a determinant of FeNO with higher levels among males compared with females, especially in studies of adults [20,22e25,42,43] , however; there are inconsistent results with some studies showing no association of FeNO with gender [19, 26, 30, 35, 44] .
Height was a significant predictor of FeNO levels in all three age groups, independent of all other covariates, including gender. This confirms results published in other studies of youths [35,45e47] and adults [19, 42, 44, 48, 49] , where FeNO values have been shown to be higher in taller persons. On the contrary, several studies have reported that height was not an independent predictor of FeNO [27, 30, 34, 43] . Age ranges and sample sizes may not have been adequate to fully investigate the relationship. We also examined BMI and FeNO levels but did not find any association.
We also examined several external factors previously shown to be related to FeNO including time of testing, second hand smoke exposure, recent ingestion of food or drink, including nitrate-rich foods, and heavy physical exercise prior to the testing. The results, however, showed no influence of any of these factors except for the time of day of the measurement where we found that FeNO levels were consistently lower in persons tested in the evening sessions. As with other factors we examined, findings from other studies on FeNO levels and diurnal variability are equivocal. In a study of circadian rhythms by Antosova and colleagues [36] , FeNO levels peaked in the AM, and Pijnenburg et al. [50] found geometric mean levels 14% higher in the morning as compared to afternoon levels. In two different studies of asthmatic youth [37, 51] there was no diurnal or day-to-day variation, and a study of children in Taiwan [29] showed FeNO measurements were lower in the mornings compared to afternoon values. The diurnal variability demonstrated in our study suggests that time of day should be considered for any serial monitoring of FeNO levels.
Results from our multiple linear regression models showed a significant relationship between FeNO and peripheral blood eosinophil count, an association that has not been previously examined in a large reference population. Despite the exclusion of NHANES participants with counts over 500 cells/mL blood from the study sample, eosinophil count remained the strongest predictor in our models in all three age groups. Although not shown, additional sensitivity analyses that excluded persons with eosinophil counts >300 cells/mL blood yielded similar results among adolescents and adults. In studies of asthma, the percent of eosinophil in induced sputum is highly correlated with airway inflammation [1] . Strunk et al. [52] found a relation between FeNO and peripheral blood eosinophil among mild to moderate asthmatic children and the association has been observed in asymptomatic atopic subjects, as well [53, 54] . Our finding that usual peripheral blood eosinophil counts were associated with FeNO levels suggests the presence of mild eosinophilic inflammation in the absence of respiratory symptoms or allergic co-morbidities, and warrants further examination. Allergic sensitization, known to significantly influence the eosinophilic count and FeNO levels [55] , was not assessed in NHANES. Several strengths and deficiencies of this analysis should be considered. NHANES has many methodological strengths including being a nationally representative cross-sectional sample, high response rates, the over-sampling of older persons and race/ethnic subgroups, and most importantly its standardized, quality control protocol for data collection. As such it is an ideal vehicle for population-based estimation to establish reference ranges for laboratory measures such as FeNO. There are, however, limitations to the current study. First, the FeNO analyzer that we used was a portable, hand-held device that did not require the degree calibration of the electro-chemical analyzers. However, the NIOX-MINO Ò does not have the precision at the lower levels of detection [2] compared to other FeNO analyzers. While nearly one-fifth of the measurements for the youth 6e11 years had levels below the limit of detection, these lower levels likely reflect a healthy constituency of the sample that resulted after the exclusion of most known respiratory conditions. Second, in assembling the reference sample of persons for analysis, it was not possible to evaluate all of the factors that are either known or hypothesized to affect FeNO measurements [8] . The NHANES population in this report was derived so as to eliminate all persons with airway diseases or respiratory symptoms, cough and cold within 7 days of the examination, as well as any current or former smokers. However persons with atopic disorders, such as chronic rhinosinustis, urticarial or eczema could not be excluded because NHANES 2007e10 did not obtain questionnaire, laboratory (i.e., serum IgE) or allergy skin test reactivity data in these areas. Data also were not collected on other medical conditions that conceivably might influence FeNO levels such as pulmonary hypertension. Higher levels of FeNO have been wellassociated with atopy and allergic rhinitis [14, 42] . Some of the higher values seen in our reference population may be a result of atopic or allergic sensitivity in the absence of reported respiratory symptoms or diagnosed asthma.
Conclusions
We have established FeNO reference values for U.S. children, adolescents and adults, free from respiratory symptoms, and lifetime nonsmokers, and have assessed the association of demographic characteristics and other cofactors with FeNO levels. Findings from our study demonstrate the variability of FeNO in the U.S. population, and the important factors that affect FeNO level, including age, height, gender, race-ethnicity, eosinophil count, as well as the time of day of the FeNO exam.
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